Signed in as:
filler@godaddy.com
Signed in as:
filler@godaddy.com
Bioinformatics, Synthetic Biology, CRISPR gene-editing, Novel Delivery Technology, Artificial Intelligence and Machine Learning applied to Biotechnology are key areas of growth opportunity in our area of expertise, poised to lead the global bioeconomy of the 21st century...
We possess decades of experience in key areas of commercial development working for startup biotech.Experienced co-founder and entrepreneur having expanded offshore entities to US locations and expanded US operations abroad.
We develop corporate strategy from the ground floor of a seed funding stage startup through growth phase licensing & partnering executions to planning a successful exit strategy.
Routine travel in US, Europe, Asia-Pacific to annual conferences such as the BIO Conference, JPMorgan Healthcare Investment Conference, BIO-Europe and Life Science Nation early stage investor (RESI) events as well as on-site visits to partner our clients with various stakeholders in the global biopharma industry.
Large network of private and institutional investors, biotech and pharma R&D, Search & Evaluation and licensing executive partners. We can help you refine your business goals from conception and formation of the company, or find the right exit with a mature growth stage company.
Our process is designed to empower your team with the tools they need to succeed.
Talk to us today about how we can support your growth and put you on a solid track to success.
Send us your information and submit a pitch deck.
E.O. Wilson on convergence of AI, Synthetic Biology, Robotics
"Synthetic Biology Will Radically Change the World"
Copyright © 2026 AGTC Ventures LLC - All Rights Reserved.
Send us a message and PDF format pitch deck (if applicable). If you don't have one that's okay, that's what we're here for.